135 related articles for article (PubMed ID: 2186820)
21. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
Saleh MN; Khazaeli MB; Wheeler RH; Bucy RP; Liu T; Everson MP; Munn DH; Schlom J; LoBuglio AF
Cancer Res; 1995 Oct; 55(19):4339-46. PubMed ID: 7671245
[TBL] [Abstract][Full Text] [Related]
22. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.
Chachoua A; Oratz R; Liebes L; Alter RS; Felice A; Peace D; Vilcek J; Blum RH
J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):132-41. PubMed ID: 7804528
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
Masucci G; Wersäll P; Ragnhammar P; Mellstedt H
Cancer Immunol Immunother; 1989; 29(4):288-92. PubMed ID: 2665935
[TBL] [Abstract][Full Text] [Related]
24. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
Curley SA; Roh MS; Kleinerman E; Klostergaard J
Lymphokine Res; 1990; 9(3):355-63. PubMed ID: 2118971
[TBL] [Abstract][Full Text] [Related]
25. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma.
Minasian LM; Yao TJ; Steffens TA; Scheinberg DA; Williams L; Riedel E; Houghton AN; Chapman PB
Cancer; 1995 May; 75(9):2251-7. PubMed ID: 7536122
[TBL] [Abstract][Full Text] [Related]
26. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
[TBL] [Abstract][Full Text] [Related]
27. Effects of rhM-CSF expressed in silkworm on cytokine productions and membrane molecule expressions of human monocytes.
Ji XH; Sun LH; Qin JC; Yao K; Ding RN; Li HD; Zhu DX
Acta Pharmacol Sin; 2000 Sep; 21(9):797-801. PubMed ID: 11501160
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
29. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.
Liesveld JL; Frediani KE; Winslow JM; Duerst RE; Abboud CN
J Cell Biochem; 1991 Apr; 45(4):381-90. PubMed ID: 1675219
[TBL] [Abstract][Full Text] [Related]
30. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
Munn DH; Cheung NK
J Exp Med; 1990 Jul; 172(1):231-7. PubMed ID: 2193096
[TBL] [Abstract][Full Text] [Related]
31. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).
VandePol CJ; Garnick MB
Biotechnol Ther; 1991; 2(3-4):231-9. PubMed ID: 1845128
[TBL] [Abstract][Full Text] [Related]
32. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes.
Hashimoto S; Yoda M; Yamada M; Yanai N; Kawashima T; Motoyoshi K
Exp Hematol; 1996 Feb; 24(2):123-8. PubMed ID: 8641333
[TBL] [Abstract][Full Text] [Related]
33. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
Blanchard DK; Serbousek D; Djeu JY
Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation.
Nagler A; Shur I; Barak V; Fabian I
Leuk Res; 1996 Aug; 20(8):637-43. PubMed ID: 8913316
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.
Ragnhammar P; Masucci G; Frödin JE; Hjelm AL; Mellstedt H
Cancer Immunol Immunother; 1992; 35(3):158-64. PubMed ID: 1638551
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.
Suzu S; Yanai N; Saito M; Kawashima T; Kasahara T; Saito M; Takaku F; Motoyoshi K
Jpn J Cancer Res; 1990 Jan; 81(1):79-84. PubMed ID: 2108950
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of release from MHC class II antigen-positive monocytes of hematopoietic colony stimulating factors CSF-1 and G-CSF by recombinant human tumor necrosis factor-alpha: synergism with recombinant human interferon-gamma.
Lu L; Walker D; Graham CD; Waheed A; Shadduck RK; Broxmeyer HE
Blood; 1988 Jul; 72(1):34-41. PubMed ID: 2455573
[TBL] [Abstract][Full Text] [Related]
39. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections.
Nemunaitis J; Meyers JD; Buckner CD; Shannon-Dorcy K; Mori M; Shulman H; Bianco JA; Higano CS; Groves E; Storb R
Blood; 1991 Aug; 78(4):907-13. PubMed ID: 1868251
[TBL] [Abstract][Full Text] [Related]
40. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
